Brookline Capital Initiates Coverage On Envoy Medical with Buy Rating, Announces Price Target of $9

Benzinga · 10/14 15:07
Brookline Capital analyst Tyler Bussian initiates coverage on Envoy Medical (NASDAQ:COCH) with a Buy rating and announces Price Target of $9.